Once weekly thyroxine treatment as a strategy to treat non-compliance.

Postgrad Med J

Department of Diabetes and Endocrinology, Royal Shrewsbury Hospital, Shrewsbury, UK.

Published: October 2007

Hypothyroidism is a common disorder, which is mainly treated in primary rather than secondary care. Once daily thyroxine replacement restores euthyroidism in most patients; some patients, however, remain hypothyroid despite adequate thyroxine replacement. Non-compliance is the most common cause of lack of response to thyroxine treatment. We describe two cases of primary hypothyroidism in which daily thyroxine treatment did not restore biochemical euthyroidism but once weekly thyroxine treatment was successful. In addition we review the evidence and discuss the differential diagnosis of lack of response to thyroxine treatment. Once weekly thyroxine treatment can be a safe, well-tolerated, and effective therapy for patients with non-compliance.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2600132PMC
http://dx.doi.org/10.1136/pgmj.2007.060244DOI Listing

Publication Analysis

Top Keywords

thyroxine treatment
24
weekly thyroxine
12
daily thyroxine
8
thyroxine replacement
8
lack response
8
response thyroxine
8
thyroxine
7
treatment
6
treatment strategy
4
strategy treat
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!